Kontour Medical's net profit falls 24.74% in 2026 interim report

Earnings
โดย Jiemian·Read original
Summary · why it matters

Kontour Medical released its 2026 interim report, with total operating revenue of 171 million yuan and net profit attributable to the parent of 41.39 million yuan, down 24.74% from the same period last year. Net cash inflow from operating activities was 59.61 million yuan, down 4.15% year-on-year. The company's asset-liability ratio was 19.23%, gross margin was 77.35%, ROE was 5.55%, and diluted earnings per share was 0.51 yuan. The number of shareholders was 4,008, and the top ten shareholders held 67.92% of the shares.

Impact on stocks 1

Others · 1 stocks